Table 3.

Blood sodium and potassium levels, plasma lactate dehydrogenase and malondialdehyde levels and lung tissue malondialdehyde levels determined at the end of the reperfusion period

Groups	Sodium	Potassium	Lactate dehydrogenase (IU/L)	Plasma malondialdehyde (μmol/L)	Lung malondialdehyde (μmol/L)
HBO group	141.36 ± 4.3	4.3 ± 1.2	622.22 ± 146.5	21.60 ± 2.3	238.04 ± 36.11
IL group	140.52 ± 3.8	4.6 ± 1.1	627.44 ± 134.2	24.19 ± 2.8	240.06 ± 32.03
HBO + IL group	142.40 ± 4.1	4.3 ± 1.0	626.50 ± 138.3	22.30 ± 2.2	236.90 ± 25.02
Control group	146.32 ± 4.4	5.2 ± 0.9	646.83 ± 167.2*	30.12 ± 1.4*	252.07 ± 46.21*
Sham group	143.60 ± 7.2	4.4 ± 1.2	625.10 ± 144.3	23.63 ± 0.13	238.08 ± 35.39

*Significantly higher than the treatment groups by analysis of variance (P <0.05). HBO: hyperbaric oxygenation; IL: iloprost.